Suppression of angiogenesis by atmospheric pressure plasma in human aortic endothelial cells
- 31 March 2014
- journal article
- conference paper
- Published by AIP Publishing in Applied Physics Letters
- Vol. 104 (13) , 133701
Abstract
Atmospheric pressure plasma (APP) has been recognized as a promising tool for cancer therapy based on its ability to remove cancer cells by causing apoptosis and necrosis. However, the effect of APP on the neighboring tissues of tumors remains unknown. Moreover, the role of APP on the vessels near tumors could be very important, because once a tumor becomes vascularized, the potential for metastasis can increase dramatically. We show in the present study that APP can induce cell cycle arrest in endothelial cells and further suppress the angiogenesis process. These results strongly support the use of APP in cancer treatment.Keywords
This publication has 21 references indexed in Scilit:
- Degradation of adhesion molecules of G361 melanoma cells by a non-thermal atmospheric pressure microplasmaNew Journal of Physics, 2009
- The Shape of Motile CellsCurrent Biology, 2009
- Adverse effects of anticancer agents that target the VEGF pathwayNature Reviews Clinical Oncology, 2009
- H2AX Is Required for Cell Cycle Arrest via the p53/p21 PathwayMolecular and Cellular Biology, 2009
- Applied Plasma MedicinePlasma Processes and Polymers, 2008
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesisMicrovascular Research, 1977
- Anti-AngiogenesisAnnals of Surgery, 1972